Cheaper EpiPen May Not Come Until End of Year, Mylan Says
- In August, company said $300 two-pack could be out in ‘weeks’
- Company says it needs to assure inventory, create packaging
Mylan's EpiPen allergy shots.
Photographer: Daniel Acker/BloombergThis article is for subscribers only.
Mylan NV’s half-price version of its EpiPen allergy shot may not be available until the end of the year, the drugmaker said in an e-mail, potentially months after a timeline the company gave in August.
The “authorized generic” version of EpiPen will be available “by the end of the year,” Mylan spokeswoman Nina Devlin said in an e-mail Monday. Five weeks ago, in a statement on Aug. 29, the company had said it expected to introduce the generic version “in several weeks.” Mylan’s generic version will cost $300 for a two-pack, about half the brand-version price.